Phase 3 Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women of reproductive age who have been diagnosed with polycystic ovary syndrome (PCOS) according to 2023 international guidelines and who also have obesity
Who may not be able to join:
- People who have diabetes, significantly reduced kidney function, chronic liver disease, or heart failure
- People whose symptoms resemble PCOS but are caused by other hormonal or glandular conditions, such as untreated thyroid problems, high prolactin levels, Cushing's syndrome, or related disorders
- People who have taken weight loss medications (such as orlistat or liraglutide) in the past three months
- People who have previously had weight loss (bariatric) surgery
- People with a condition known to cause unintended weight loss, such as an overactive thyroid, Addison's disease, cancer, chronic infection, or certain connective tissue disorders
- People whose weight gain is likely caused by another condition or medication, such as a major mood disorder, or regular use of steroids, valproate, or the oral contraceptive pill
- People for whom the study medication (semaglutide) would not be considered safe, including those with a personal or family history of a specific type of thyroid cancer (medullary thyroid carcinoma), a history of acute pancreatitis, or gallbladder disease
- People who are currently pregnant, breastfeeding, or planning to become pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Muhammad Abul Hasanat, MD, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Phone: +880 1711-670735
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Weight; Body mass index; Waist circumference; Hip circumference; Blood pressure; Acanthosis nigricans; Fasting plasma glucose; Fasting insulin; Homeostasis model assessment of insulin resistance; Total cholesterol; HDL-cholesterol; LDL-cholesterol; Triglyceride
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.